| 摘要 |
<p>This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. The compounds are useful in the treatment of hepatitis C and are of the following general structure: Formula (I)</p> |
| 申请人 |
ABBOTT LABORATORIES |
发明人 |
DONNER, PAMELA L.;RANDOLPH, JOHN T.;KRUEGER, ALLAN C.;BETEBENNER, DAVID A.;HUTCHINSON, DOUGLAS K.;LIU, DACHUN;LIU, YAYA;LONGENECKER, KENTON L.;MARING, CLARENCE J.;PRATT, JOHN K.;ROCKWAY, TODD W.;STEWART, KENT D.;WAGNER, ROLF;BARNES, DAVID M.;CHEN, SHUANG;FRANCZYK II, THADDEUS S.;GAO, YI;HAIGHT, ANTHONY R.;HENGEVELD, JOHN E.;HENRY, RODGER F.;KOTECKI, BRIAN J.;LOU, XIAOCHUN;ZHANG, GEOFF G. Z. |
